Oct. 17, 2023

An article by the Associated Press (AP) published Oct. 17 considers, “Are 3D mammograms better than standard 2D imaging for catching advanced [breast] cancers?” The Tomosynthesis Mammographic Imaging Screening Trial (TMIST), discussed in the article and managed daily by the American College of Radiology® (ACR®) Center for Research and Innovation, intends to find out.

The National Cancer Institute-funded TMIST study — one of the most diverse cancer screening trials in history — already has nearly 93,000 of the planned 128,000 participants enrolled. The AP reports, “At the U.S. study sites, 21% of study participants are Black women — that’s higher than a typical cancer treatment study, in which 9% of participants are Black.”

The AP quotes Etta Pisano, MD, FACR, ACR Chief Research Officer, who shared that the study, led by the ECOG-ACRIN Cancer Research Group, “added more international sites to enhance the trial’s diversity, particularly for Hispanic and Asian women.”

For more information, visit acr.org/TMIST.


Related ACR News

  • State Legislative Bills Report

    As most state legislatures end their 2025 sessions and look to 2026, ACR staff is looking at how some radiology-specific bills they tracked fared this year.

    Read more
  • Medicare Payment Increase in Final Budget Reconciliation Bill

    The bill includes a 2.5% increase to the Medicare Physician Fee Schedule for calendar year 2026.

    Read more
  • CMS Announces Prior Authorization Test Model

    WiSer is a six-year program that will begin in six states on January 1, 2026. It will introduce prior authorization using AI technology for a select number of services, including some IR procedures.

    Read more